Aldehyde modulator
This page covers all Aldehyde modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Aldehyde dehydrogenase (ALDH) / reactive aldehydes.
Targets
Aldehyde dehydrogenase (ALDH) / reactive aldehydes
Phase 3 pipeline (1)
- ICM ADX-2191 injection · Aldeyra Therapeutics, Inc. · Immunology
ADX-2191 is a reactive aldehyde species that inhibits aldehyde dehydrogenase (ALDH) to modulate immune and inflammatory responses.
Patent intelligence
- aldehyde modulator patent landscape — aggregated cliff calendar, attackable patents, originator estates